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Abstract 
Background: Boric acid is widely used in biology, but its body weight reducing effect is not 
researched.  
Methods: Twenty mice were divided into two equal groups. Control group mice drank 
standard tap water, but study group mice drank 0.28mg/250ml boric acid added tap water 
over five days. Total body weight changes, major organ histopathology, blood biochemistry, 
urine and feces analyses were compared. 
Results: Study group mice lost body weight mean 28.1% but in control group no weight loss 
and also weight gained mean 0.09% (p<0.001). Total drinking water and urine outputs were 
not statistically different. Cholesterol, LDL, AST, ALT, LDH, amylase and urobilinogen levels 
were statistically significantly high in the study group. Other variables were not statistically 
different. No histopathologic differences were detected in evaluations of all resected major 
organs. 
Conclusion: Low dose oral boric acid intake cause serious body weight reduction. Blood and 
urine analyses support high glucose, lipid and middle protein catabolisms, but the mechanism 
is unclear. 
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Introduction 
Boron is a very stable ametal and in nature it is 
found  as  borates.  Borates  are  chemical  compounds 
which contain oxoanions of boron. The natural borate 
content of groundwater and surface water is usually 
small.  Concentrations  of  boron  in  groundwater 
throughout the world range widely, from 0.3 to 100 
mg/litre. Concentrations of boron in drinking water 
have wide ranges, depending on the source, but for 
most  of  the  world  the  range  is  estimated  to  be  be-
tween 0.1 and 0.3 mg/litre. The richest sources of bo-
ron are fruits, vegetables, pulses, legumes, and nuts. 
Dairy products, fish, meats, and most grains are poor 
sources of boron. The mean daily intake of boron in 
the diet is estimated to be near 1.2 mg/day (1).  
Boron is immediately to the left of carbon atom 
in the periodic table. It is very similar to carbon atoms, 
so many carbon-based molecules are the same as the 
boron-based  molecules.  The  most  important  differ-
ence between boron and carbon is its smaller atomic 
structure.  For  that  reason  boron  has  been  used  for 
about 30 years in boron neutron capture therapy (2). 
Carbon creates chain- or ring-shaped molecules, but 
boron creates very different forms -- cages, clusters, 
etc (3).  
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The essential role of the trace element boron in 
plants has long been established (4). 
Boron  is  an  essential  nutrient  for  animals  (5). 
Boron is used in a wide range of products, including 
glass,  detergents,  fire  retardants,  fibers  to  reinforce 
plane  fuselages  and  body  armor,  and  in  superhard 
materials (3).  
In this research we aimed to investigate the ef-
fects  of  oral  boric  acid  intake  on  body  weight.  We 
hypothesized  that  low  dose  oral  boric  acid  intake 
causes seriously weight loss without any side effects. 
Methods 
This study was performed at the Experimental 
Animal Production and Research Laboratory of Cer-
rahpasa Medical School, Istanbul University and was 
approved  by  the  appropriate  Animals  Ethics  Com-
mittee.  All  protocols  were  in  accordance  with  the 
regulations governing the care and use of laboratory 
animals of the declaration of Helsinki.  
Mice were divided into two groups, with 10 mice 
in each group. Eight weeks old twelve bal-c out-bred 
female  mice  were  used.  The  animals  were  kept  in 
standard  metabolic  cages  specifically  for  mice  from 
which  daily  urine  and  feces  were  detectible.  A 
12-hour light/12-hour dark cycle was used for illu-
mination of the room where mice were placed.  
Boric acid intake of mice was provided by add-
ing it to drinking water. 0.28mg boric acid (2mg Bor 
Atac DF®, %14 Boric Acid, TMT Co, Tekirdag, Tur-
key) added 250ml tap water and melted with 3 min. 
agitation.  
In day 0, mice were put in metabolic cages after 
weighing. Per days they were weighed ante meridiem 
and data recorded. In five days, mice were fed with 
standard  pellet  feed  manufactured  specifically  for 
small animals and drank boric acid added tap water. 
No any eat or drink changing or limitation was used.  
After  five  days  total  urine  and  feces  uptakes 
recorded  and  animals  were  sacrificed  with  cervical 
dislocation. Anterior midline abdomino-thoracal inci-
sion was performed and for analyses of blood serum 
parameters cardiac puncture was performed with 21 
gauge sterile injector. After the aspiration major ab-
dominal organs; liver, spleen, stomach, intestine, co-
lon, and thoracic organs; thyroid, thymus and with 
cranial incision brain were resected. 
Premier  evaluation  parameter  of  this  study  is 
total body weight changes of mice. Secondary evalu-
ation  parameters  were;  histopathologic  changes  of 
major  organs,  changes  of  blood  biochemistry,  total 
urine volume, urine uroblinogen level, feces volume 
and gall acids in feces. 
Morphological  Evaluation:  After  resection,  all 
organs were fixed in formula. After dehydration, they 
were embedded in paraffin. Cross sections of 5 mm 
were prepared, stained with hematoxylin and eosin, 
and evaluated by light microscopy at a magnification 
of  x100.  All  evaluations  were  performed  by  a 
pathologist who was blinded to methods and groups.  
Statistical Evaluation:  Statistical analyses were 
performed using GraphPad Prisma V.3 software. Re-
sults were evaluated with a confidence interval of 95% 
and p<0.05 level. In addition to descriptive statistical 
methods  (mean,  standard  deviation,  median),  the 
Mann  Whitney  U  (MWU)  test  for  inter-group  com-
parisons,  the  Wilcoxon  test  for  comparison  of 
in-group variables. 
Results 
Amount of main daily drinking water values of 
the groups was not statistically different between the 
groups (3.18ml in control group and 3.50ml in study 
group, p= 0.433, z= -0.784). In calculation, mice in the 
study group received approximately 0.2mg/kg/day 
of boric acid. 
Body weight changes of the groups and statisti-
cal analyses are revealed in Table 1. Study group mice 
lost body weight at a mean 28.1% in five days but in 
control group no weight loss; their weight gain aver-
aged  0.09%.  Body  weight  changes  in  study  group 
were statistically more significant than control group 
(p<0.001). Day 0, day 5 body weight differences were 
not statistically significant in control group but sig-
nificant in study group (p=0.005). 
Total drinking water and urine outputs were not 
statistically different in the groups (table 1). Choles-
terol, LDL, AST, ALT, LDH, amylase and urobilino-
gen levels were statistically significant high in study 
group. Other variables were not statistically different 
(table 1).  
No histopathologic differences were detected in 
evaluations  of  all  resected  organs;  liver,  spleen, 
stomach, intestine, colon, thyroid, thymus and brain. 
Discussion 
Boron  is  widely  used  in  medicine.  Boron  sup-
plementation  in  rats’  diets  enhances  liver  glycogen 
deposition  (6)  and  in  chicks’  diets  increases  shear 
fracture energy of the bones (7, 8). Boron supplemen-
tation  of  a  semipurified  diet  for  weaning  pigs  im-
proves feed efficiency and alters plasma lipid metab-
olites (9). Boron influences the serine proteases, where 
boron forms a tetrahedral adduct with the active site 
of serine (10). In human study of Nielsen et al., sup-
plemental  boron  increased  serum  testosterone  and 
estradiol  concentrations  in  postmenopausal  women Int. J. Med. Sci. 2011, 8 
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(11). Because of the atomic structural similarity boron 
is an alternative to carbon in drug design. Boromycin, 
an  antibiotic  compound  produced  by  streptomyces. 
The  first  clinically  tested  boron-based  drug  is 
Velcade®  (bortezomib,  Millennium  Pharm.,  USA) 
which is used to treat multiple myeloma (12).  
The  acting  range  of  boron  is  very  wide  but 
physiological  and  metabolic  mechanisms  are  not 
clear. An important role of boron is metabolic regula-
tion, because it complexes with a variety of substrate 
or reactant compounds in which there are hydroxyl 
groups in favorable positions (13). 
The  oxidoreductase  enzymes  are  competitively 
inhibited in vitro by borate or its derivatives which 
require pyridine or flavin nucleotides, are inhibited as 
borate competes for NAD, or flavin co factor. Some 
examples are aldehyde dehydrogenase (14), xanthine 
oxidase (15), and cytochrome b5 reductase (16). Borate 
apparently  complexes  with  the  ribosyl  cishydroxy 
groups  of  NAD  (17).  Key  pathways  of  energy  sub-
strate metabolism contain members of oxidoreductase 
enzymes that are inhibited by boron. There is consid-
erable evidence that physiologic amounts of dietary 
boron modulate both energy substrate utilization and 
mineral metabolism (15-17).  
 
Table 1: Body weight changing and variables of the groups with statistical analyses 
  Control Group  Study Group     
Mean  Median  Std. Dev.  Mean  Median  Std. Dev.  z  p 
Day 0 
Body Weight 
(g) 
21,10  21,00  1,31  20,60  20,00  2,51  -,956  0,339 
Day 5 
Body Weight 
(g) 
21,30  21,00  1,16  14,80  14,75  1,30  -3,797  <0,001 
Body Weight 
Difference (g) 
0,20  0,00  0,95  -5,80  -5,75  1,74  -3,792  <0,001 
Drinking water 
(ml/5 days) 
16,90  17,00  2,08  17,50  17,00  1,51  -,784  0,433 
Creatinin (mg/dl)  0,16  0,15  0,07  0,15  0,15  0,05  -,213  0,831 
Cholesterol 
(mg/dl) 
78,30  78,00  16,63  151,30  142,00  27,93  -3,781  <0,001 
Trigliserid 
(mg/dl) 
80,50  81,50  17,28  94,50  82,00  27,70  -,946  0,344 
HDL (mg/dl)  31,50  30,50  10,00  53,20  51,00  9,90  -3,187  0,001 
LDL (mg/dl)  15,20  16,00  4,78  81,00  75,00  22,54  -3,784  <0,001 
Albumine (g/dl)  3,56  3,50  0,35  3,63  3,60  0,31  -,582  0,561 
AST 
(U/l) 
331,30  281,00  203,40  739,70  717,00  244,44  -3,099  0,002 
ALT 
(U/l) 
44,60  40,00  20,47  81,60  66,00  46,72  -2,649  0,008 
Na 
(mmol/l) 
140,80  141,50  2,82  141,30  141,00  3,13  -,420  0,675 
K 
(mmol/l) 
4,24  4,30  0,62  4,16  4,15  0,56  -,152  0,879 
Ca 
(mg/dl) 
8,73  8,55  0,46  8,79  8,90  0,39  -,343  0,732 
LDH 
(U/l) 
973,90  996,50  467,67  2362,20  2309,00  405,14  -3,704  <0,001 
CK  4433,40  4526,50  1427,82  5648,50  5914,00  1827,28  -1,663  0,096 
CKMB  6059,30  6385,00  1124,87  6138,60  6373,00  1393,36  -,227  0,821 
Amilaz (U/l)  2678,70  2345,50  756,16  3437,90  3272,00  593,17  -2,192  0,028 
Lipaz (U/l)  59,30  60,00  15,87  59,00  65,00  13,52  -,152  0,879 
Total bilirubine (mg/dl)  0,00  0,00  0,00  0,00  0,00  0,00  ,000  1,000 
Direct bilirubine (mg/dl)  0,00  0,00  0,00  0,00  0,00  0,00  ,000  1,000 
Total protein (g/dl)  5,94  6,00  0,23  5,90  5,80  0,37  -,660  0,509 
Fecal Bile Acids (mg)  2,20  2,00  0,42  2,10  2,00  0,32  -,610  0,542 
Urobilinogen 
(mg/dl) 
2,00  2,00  0,82  3,60  4,00  0,52  -3,466  0,001 
Urine Volume 
(ml/5 days) 
9,30  9,50  1,06  8,90  9,00  1,20  -,783  0,434 Int. J. Med. Sci. 2011, 8 
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Blevins et al. revealed that boron may alter me-
tabolism  by  regulating  activation  of  manganese  en-
zymes and/or ametal activated enzymes. They have 
shown  that  boron  inhibits  certain  enzymes,  e.g., 
6-phosphogluconate  dehdrogenase  and  aldolase,  by 
binding to substrates or enzyme substrate complexes 
in plants (18). Lots of studies have shown that sup-
plemental  boron  stimulates  proton  pumping  in 
plants,  causes  hyperpolarization  of  the  membrane 
potential,  and  increases  potassium  uptake.  Along 
with these findings, there have been reports of a bo-
ron-mediated  increase  in  ferricyanide  reduction 
(19-22).  There  is  also  strong  evidence  that  boron  is 
involved  in  lignin  biosynthesis  and  in  cell  wall 
cross-linking in plants (23). Barr and Morre et al hy-
pothesized  that  the  effects  of  boron  on  membrane 
function may be associated more directly with proton 
pumping or changes in a redox system in the plasa-
malemma (24, 25). 
Although suggested amount of boron is 3mg/kg 
diet for animals (26) but daily boron intake is changed 
in wide ranges and toxic doses are very high. Toxicity 
studies focused on short-term and long-term exposure 
results of boric acid. In a 13-week study, mice were 
fed diets containing boric acid at approximately 0, 34, 
70, 141, 281, or 563 mg of boron per kg of body weight 
per day. At the two highest doses, increased mortality 
and degeneration or atrophy of the seminiferous tu-
bules was observed. In all dose groups, extramedul-
lary haematopoiesis of the spleen of minimal to mild 
severity  was  seen  (27).  In  the  same  study,  mice  re-
ceived approximately 0, 275, or 550 mg of boric acid 
per kg of body weight per day in the diet in two years. 
This research demonstrated that increased mortality 
rates and non-neoplastic testicular lesions in males. In 
the 2-year study, the dogs received the boric acid in 
the diet 0, 1.5, 2.9, or 8.8mg per kg of body weight per 
day. An additional group received 29mg of boron per 
kg of body weight per day for 38 weeks. Testicular 
atrophy was observed in two test dogs receiving bo-
rax at 26 weeks and in the two and one dogs, respec-
tively, killed after 26 or 38 weeks of boric acid con-
sumption. (28).  
The mutagenic activity of boric acid was exam-
ined  in  mouse,  hamster,  mouse  embryo  cells,  and 
human fibroblasts but revealed that boric acid does 
not  cause  any  gene  mutations  (29,  30).  Tumor  inci-
dence was not enhanced in studies in which B6C3F1 
mice received 0, 2500, or 5000 mg of boric acid per kg 
of feed for 103 weeks (27) and Sprague-Dawley rats 
received diets containing 0, 117, 350, or 1170 mg of 
boron per kg of feed for 2 years (28). 
In  this  research,  we  revealed  that  low-dose 
(0.2mg/kg)  oral  boric  acid  intake  cause  seriously 
body weight reducing in five days and applied Turk-
ish  Patent  Institude  (date:  May,27,2011;  no: 
2011/05210).  In  literature research,  we  did  not  find 
any  data  about  the  effects  of  boric  acid  on  body 
weight reduce except Willig and Curtze’s research in 
1952. But we could not reach the full text and/or ab-
stract of this article (31). Oppositely some animal re-
searches  revealed  that  over  physiologic  amounts 
(3mg/kg/day)  of  dietary  boron  supplementation 
causes weight gaining (10). Some toxicity researches 
expressing  body  weight  reducing  in  the  high  boric 
acid intake doses. In the Lee et al. study with rats at 
concentrations of 0, 500, 1000, or 2000 mg of boron per 
kg  of  feed  for  30  or  60  days,  reported  that  body 
weights were not consistently affected (32). Weir et al. 
revealed that received 88 mg boron per kg of body 
weight  per  day  reduced  rats’  body  weights  (28).  A 
toxicology  study  done  by  the  US  Department  of 
Health  and  Human  Services  demonstrated  that  275 
and 550 mg of boric acid per kg of body weight per 
day intake mice reduced body weights 10–17% after 
32 weeks (27).  
Our study reveals that very low dose (0.2mg/kg) 
oral  boric  acid  intake  ensures  serious  body  weight 
reduction  in  mice.  To  express  this  dramatic  body 
weight  loss  (28.1%)  in  a  short  time  period  we  hy-
pothesized firstly that boric acid had a diuretic effect. 
We collected urine output but reached no statistical 
differences  compared  with  the  control  group.  Sec-
ondarily, we analyzed blood biochemistry, urine, fe-
ces  and  evaluated  major  organ  histopathology.  We 
reached that only blood cholesterol, LDL, AST, ALT, 
LDH,  amylase  and  urine  urobilinogen  levels  were 
statistically high in the study group.  
It is clear that in the animal and human biology 
energy  sources  is  sequencing  by  glucose,  lipid  and 
protein expenditure. We hypothesized that high am-
ylase  (glucose  elimination  enzyme),  cholesterol  and 
LDL levels are results of high glucose and lipid ca-
tabolism.  According  to  this  opinion,  -as  a  protein 
elimination  enzyme-  CK  values  were  high  in  the 
study group but not statistically different in the con-
trol group level. The result of high catabolic metabo-
lism,  high  levels  of  AST,  ALT  and  urobilinogen  as 
hepatic function markers supports this hypothesis.  
In summary, this research shows that low dose 
oral  boric  acid  intake  cause  seriously  body  weight 
reducing.  Our  blood  and  urine  analyses  results  are 
supporting  high  glucose,  lipid  and  middle  protein 
catabolisms, but the mechanism is unclear.  
Maintenance of obesity treatment and success of 
weight  loss  is  highly  variable  and  include  some  of 
serious questions (33). Adipose tissue and its glucose 
and lipid related metabolism is the target area. Insulin Int. J. Med. Sci. 2011, 8 
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sensitivity and other indexes of insulin secretion or 
action  have  been  associated  with  changes  in  body 
weight  or  composition  (34,35).  Various  aspects  of 
glucose  and  lipid  metabolism  have  been  linked  to 
individual  differences  in  energy  balance  over  time. 
The most widely studied is insulin sensitivity (33-36). 
Life time of adipocytes is other important point for 
obesity treatment (37,38). Inducing apoptosis of adi-
pocytes may be most effective way to weight loss.  
There  are  some  questions  that  have  not  found 
answers. Effects of different doses of boric acid intake 
on body weight must be evaluated. Additionally the 
effects of low dose oral boric acid intake on different 
kind of laboratory animals (such as rats, rabbits) must 
be evaluated, especially the mechanism of action. For 
this reason we are planning a full complement of boric 
acid dose as well as other kinds of studies on animal. 
We will perform cell proliferation assay and real time 
PCR analyses on adipose tissue derived mesenchymal 
stem cells for evaluation of molecular changes in the 
adipose tissue level. 
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